Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Long-standing diabetes patients with pre-existing eye conditions that require ongoing monitoring
Decrease food intake Enhances insulin secretion Improves insulin sensitivity Additional actions include delayed gastric emptying* and reduced glucagon levels *This effect diminishes over time
If you want to see where a repair peptide like this would sit in your own case, learn more about getting started with Dr
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes management, administered as a once-weekly subcutaneous injection
US$ 20.55
US$ 26.83
US$ 28.81
US$ 26.77
